GeneBio Appoints Mark Pitman to Run North American Business Operations
Mr. Pitman will focus his efforts on GeneBio's flagship product Phenyx. Mark will also work towards expanding GeneBio's industry partnerships in the mass spectrometry field in order to provide more comprehensive value-added solutions to customers, a role at which he excelled with his previous employer.
"The creation of this new position in North America testifies to the importance of this region in our proteomics business and to GeneBio's commitment to play an ever-increasing role in this fast-evolving MS market," said Nasri Nahas, CEO of GeneBio. "The addition of Mark to GeneBio's highly dynamic team brings us someone well respected in the field who is intimately familiar with our product offerings. An opportunity like this does not present itself very often; we are glad to have Mark on board and look forward to his contributions and future success."
Most read news
Organizations
Other news from the department people
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!